Your browser is no longer supported. Please, upgrade your browser.
GSK GlaxoSmithKline plc weekly Stock Chart
GlaxoSmithKline plc
Index- P/E19.01 EPS (ttm)2.07 Insider Own0.20% Shs Outstand2.52B Perf Week0.13%
Market Cap99.15B Forward P/E12.96 EPS next Y3.04 Insider Trans0.00% Shs Float2.47B Perf Month-1.15%
Income5.16B PEG2.00 EPS next Q0.66 Inst Own11.50% Short Float0.28% Perf Quarter-4.60%
Sales40.00B P/S2.48 EPS this Y42.70% Inst Trans4.58% Short Ratio2.84 Perf Half Y-3.67%
Book/sh2.08 P/B18.94 EPS next Y4.22% ROA6.60% Target Price44.33 Perf Year-1.77%
Cash/sh2.14 P/C18.39 EPS next 5Y9.50% ROE94.50% 52W Range36.41 - 42.36 Perf YTD3.09%
Dividend2.39 P/FCF26.00 EPS past 5Y-7.40% ROI16.00% 52W High-7.01% Beta0.74
Dividend %6.07% Quick Ratio0.50 Sales past 5Y3.10% Gross Margin68.70% 52W Low8.18% ATR0.46
Employees95490 Current Ratio0.70 Sales Q/Q6.10% Oper. Margin18.20% RSI (14)39.59 Volatility0.88% 0.99%
OptionableYes Debt/Eq7.91 EPS Q/Q50.20% Profit Margin12.50% Rel Volume0.93 Prev Close39.39
ShortableYes LT Debt/Eq5.82 EarningsMay 01 BMO Payout78.80% Avg Volume2.39M Price39.39
Recom2.00 SMA20-1.44% SMA50-2.91% SMA200-1.44% Volume2,230,868 Change0.00%
Mar-08-19Downgrade Shore Capital Buy → Hold
Feb-22-19Downgrade UBS Buy → Neutral
Jan-14-19Downgrade Exane BNP Paribas Outperform → Neutral
Dec-11-18Resumed Jefferies Buy
Oct-09-18Initiated Guggenheim Neutral
Aug-30-18Downgrade Liberum Buy → Hold
Apr-04-18Upgrade Exane BNP Paribas Neutral → Outperform
Mar-22-18Upgrade Morgan Stanley Underweight → Equal-Weight
Feb-09-18Upgrade Kepler Reduce → Hold
Nov-06-17Downgrade Investec Buy → Hold
Oct-26-17Downgrade BofA/Merrill Buy → Neutral
Sep-08-17Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-05-17Downgrade Citigroup Buy → Neutral
May-26-17Upgrade Berenberg Hold → Buy
Apr-05-17Upgrade Exane BNP Paribas Underperform → Neutral
Mar-09-17Initiated Liberum Buy
Mar-09-17Initiated Kepler Reduce
Oct-20-16Initiated Investec Buy
Sep-23-16Initiated Piper Jaffray Overweight
Jul-14-16Upgrade Jefferies Hold → Buy
May-21-19 08:46AM  Merck's Keytruda Fails in Late-Stage Breast Cancer Study Zacks
08:13AM  Merck agrees $1bn deal to buy biopharmaceutical company Peloton Financial Times
07:08AM  Edited Transcript of GSK.L earnings conference call or presentation 1-May-19 1:00pm GMT Thomson Reuters StreetEvents
May-20-19 02:44PM  Primary Drivers of the Chinese Economy Investopedia
May-17-19 09:13AM  Thermo Fisher Acquires GlaxoSmithKline's Drug Production Site Zacks
02:14AM  GSK and Novartis liniment marketing misled Australian consumers - court Reuters
May-16-19 11:49AM  How to Invest in Biotech: Known Your Catalysts
05:00AM  Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland, from GSK PR Newswire
May-15-19 07:00AM  Matinas BioPharma Announces a Research Collaboration with ViiV Healthcare to Evaluate Formulation of Antiviral Drug Candidates GlobeNewswire
May-14-19 02:02AM  Stanford Dad Accused of $6.5 Million Payment in College Scandal Has a New Problem Bloomberg
May-12-19 11:00AM  Top vaccine makers Merck and Pfizer target China and older adults next CNBC
10:02AM  The money behind vaccines CNBC Videos
May-08-19 09:37PM  GSK-Pfizer deal gets approval from Australia's anti-trust watchdog Reuters
09:02PM  Australia's anti-trust watchdog gives go-ahead for GSK-Pfizer consumer healthcare deal Reuters
11:44AM  Theravance (TBPH) Q1 Loss Widens, Revenues Miss Estimates Zacks
09:46AM  Clovis (CLVS) Q1 Earnings Top Estimates, Rubraca Sales Strong Zacks
May-07-19 04:54PM  What's in Store for Axsome (AXSM) This Earnings Season? Zacks
May-06-19 09:21AM  The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo Zacks
May-04-19 01:09PM  UK's Vectura wins patent infringement case against GlaxoSmithKline in U.S Reuters
12:24PM  UK's Vectura wins patent infringement case against GlaxoSmithKline in U.S. Reuters
May-03-19 03:41PM  Emergent (EBS) Earnings & Revenues Miss Estimates in Q1 Zacks
10:45AM  Gilead (GILD) Earnings Beat, Revenues Miss Estimates in Q1 Zacks
06:10AM  Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod Zacks
02:56AM  UK Stocks-Factors to watch on May 3 Reuters
01:28AM  UK Stocks-Factors to watch on May 3 Reuters
May-02-19 11:51PM  Investors Chronicle: Greene King, Standard Chartered, GlaxoSmithKline Financial Times
01:46PM  GSK's 3-in-1 inhalable drug shows promise in asthma study Reuters
01:20PM  GSK's Trelegy Ellipta meets key goal in late-stage asthma study Reuters
10:00AM  Is GlaxoSmithKline a Buy? Motley Fool
09:16AM  Glaxo (GSK) Beats on Q1 Earnings & Sales, Shingrix Impresses Zacks
May-01-19 05:58PM  GlaxoSmithKline plc (GSK) Q1 2019 Earnings Call Transcript Motley Fool
02:08PM  GSK sees shingles vaccine sales rising, as free cash flow concerns weigh Reuters
01:08PM  GSK sees shingles vaccine sales rising, as free cash flow concerns weigh Reuters
09:34AM  Can Allergan (AGN) Beat Earnings Estimates Again in Q1? Zacks
07:44AM  Glaxo (GSK) Beats Earnings & Revenue Estimates in Q1 Zacks
07:39AM  GSK sales boosted by shingles and HIV treatments success Financial Times
07:29AM  GSK first-quarter beats estimates on shingles vaccine surge Reuters
Apr-30-19 11:05PM  Stocks to watch: Sainsburys, Pearson, Just Eat, GSK Financial Times
09:33AM  Pfizer (PFE) Beats on Q1 Earnings & Sales, Raises EPS View Zacks
08:32AM  What's in Store for ANI Pharmaceuticals (ANIP) Q1 Earnings? Zacks
08:02AM  What's in Store for BioSpecifics (BSTC) This Earnings Season? Zacks
Apr-29-19 04:41PM  Arcus (RCUS) to Report Q1 Earnings: What's in the Cards? Zacks
10:53AM  Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards? Zacks
09:43AM  Teva (TEVA) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-26-19 04:07PM  Will HIV Franchise Sales Drive Gilead's (GILD) Q1 Earnings? Zacks
02:01PM  Is a Beat in Store for Glaxo (GSK) This Earnings Season? Zacks
11:43AM  GSK's HIV drug wins European panel thumbs-up Reuters
Apr-25-19 11:50AM  Can Keytruda Drive Merck's (MRK) Q1 Earnings and Sales? Zacks
10:08AM  Pfizer Stock Has Positive and Negative Catalysts Going Into Results InvestorPlace
09:42AM  Exelixis (EXEL) to Report Q1 Earnings: What's in Store? Zacks
Apr-24-19 09:03PM  Top 5 Dividend Stocks in the FTSE for 2018 Investopedia
04:45PM  Lannett (LCI) to Report Q3 Earnings: What's in the Cards? Zacks
04:25PM  Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards? Zacks
01:55PM  Drug maker to spend $100M expanding Montana facility Associated Press
10:02AM  Novartis (NVS) Q1 Earnings Beat Estimates, Revenues Up Y/Y Zacks
03:27AM  Malawi starts pilot of malaria vaccine for children Financial Times
Apr-23-19 09:46AM  Alexion (ALXN) to Report Q1 Earnings: What's in the Cards? Zacks
09:27AM  What's in Store for Celgene Corporation (CELG) Q1 Earnings? Zacks
09:10AM  Are Investors Undervaluing GlaxoSmithKline (GSK) Right Now? Zacks
08:44AM  2 Best Biotech Buyout Plays Motley Fool
Apr-22-19 04:42PM  What's in Store for Bayer (BAYRY) This Earnings Season? Zacks
08:30AM  Will Bristol-Myers (BMY) Disappoint This Earnings Season? Zacks
Apr-19-19 10:43AM  GSK cutting employees at its R&D unit in Collegeville American City Business Journals
Apr-18-19 11:29AM  Clovis Focuses on Rubraca Label Expansion, Competition Stiff Zacks
Apr-17-19 02:30PM  COPD space about to have another drug this time from a Morrisville concern American City Business Journals
11:01AM  Emergent's (EBS) Chikungunya Vaccine Positive in Phase II Study Zacks
Apr-16-19 11:07AM  Axsome's AXS-05 Meets Goal in Phase II Study, Shares Up Zacks
10:57AM  Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA Zacks
Apr-15-19 09:57AM  Clovis Stalls Mid-Stage Rubraca Study for Bladder Cancer Zacks
05:28AM  London's FTSE 100 tugged down by miners; IWG lifts midcaps Reuters
Apr-12-19 11:08AM  Merck's Keytruda Gets FDA Nod for Expanded Lung Cancer Group Zacks
10:30AM  Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal Zacks
Apr-11-19 06:20PM  Novartis to Market Rizmoic Through Sandoz, Spins Off Alcon Zacks
Apr-10-19 10:14AM  AstraZeneca/Merck's Lynparza Wins EU Nod for Breast Cancer Zacks
Apr-09-19 11:19AM  Dont Give Up on Gilead Stock After GlaxoSmithKline Beat It to a New HIV Drug, Analyst Says
10:59AM  Emergent's (EBS) Strong Vaccine Portfolio to Fuel Growth Zacks
08:02AM  Glaxo's Dovato Gets FDA Nod for Treatment-Naive HIV Patients Zacks
Apr-08-19 05:25PM  Gilead Files sNDA for Label Expansion of HIV Therapy Descovy Zacks
04:51PM  GSK wins U.S. nod for two-drug HIV combination Reuters
03:56PM  U.S. FDA approves GSK's two-drug HIV treatment Reuters
03:46PM  U.S. FDA approves GSK's two-drug HIV treatment Reuters
10:00AM  3 Top Biotech Stocks to Buy in April Motley Fool
04:26AM  GSK two-drug/one-pill HIV treatment given FDA approval in US Financial Times
Apr-05-19 08:00AM  Health Day Checkup of Medical ETFs: 5 Top Picks Zacks
Apr-04-19 09:39AM  Novartis Resubmits BLA to FDA for Biosimilar of Neulasta Zacks
Apr-03-19 10:22AM  Clovis Posts Data on Rubraca Study for Pancreatic Cancer Zacks
Apr-02-19 10:18AM  Novartis Gets Approval for Psoriasis Drug Cosentyx in China Zacks
10:04AM  Merck's Keytruda Gets Nod for First-Line Lung Cancer in China Zacks
Apr-01-19 02:31PM  Top Analyst Reports for Chevron, IBM & Medtronic Zacks
08:53AM  3 Big Pharma Stocks to Add to Your Portfolio This April Zacks
Mar-29-19 08:10PM  3 Dividend Stocks That Pay You Better Than Coca-Cola Does Motley Fool
12:45PM  Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates Benzinga
12:10PM  The Brexit Day That Wasn't Leaves Britain Counting the Cost Bloomberg
Mar-28-19 01:29PM  European shares give up gains as banks weigh amid concerns on growth, Brexit Reuters
09:52AM  One Key Strategy to Build Your Ultimate Retirement Portfolio InvestorPlace
Mar-27-19 02:47PM  5 Cancer-Fighting Stocks to Boost Portfolio Gains Zacks
09:33AM  Were Hedge Funds Right About Deserting GlaxoSmithKline plc (GSK)? Insider Monkey
Mar-26-19 07:45PM  Better Buy: Eli Lilly vs. GlaxoSmithKline Motley Fool
Mar-22-19 07:00AM  FOCUS-UPS eyes in-home health services with U.S. vaccine project Reuters
01:00AM  FOCUS-UPS eyes in-home health services with U.S. vaccine project Reuters
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Sensodyne, parodontax, Poligrip, Voltaren, Panadol, Otrivin, and Theraflu brand names. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, pods, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, and malted drinks and foods. Its primary collaboration is with 23andMe; and strategic alliance is with Merck KGaA to jointly develop and commercialize M7824. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLCDirectorApr 22Buy18.00325,0005,850,0001,992,550Apr 24 07:28 PM
GLAXOSMITHKLINE PLCFormer 10% holderJul 30Buy11.00148,8181,636,998624,422Aug 01 06:32 PM
GLAXOSMITHKLINE PLC10% OwnerJul 17Buy12.5080,0001,000,0001,934,006Jul 17 05:01 PM
GLAXOSMITHKLINE PLC10% OwnerJul 02Buy13.00269,2303,499,9903,697,912Jul 03 05:59 PM